Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Lynozyfic
Generic name : Invoseltamab
Manufactured By : Regeneron Pharmaceuticals Inc
Indications : Relapsed or refractory multiple myeloma (RRMM)
Medicine Description : Invoseltamab (linvoseltamab, brand name Lynyzofic) is a bispecific monoclonal antibody that targets BCMA on myeloma cells and CD3 on T cells, activating T cells to destroy cancer cells. It is FDA- and EMA-approved for relapsed or refractory multiple myeloma after multiple prior therapies. Trials show ~70% response rates with durable remissions. Key risks include cytokine release syndrome, neurotoxicity, cytopenias, and infections.